J. J. Michiels
Goodheart Institute and Foundation,
Anand P Jillella
Director, Bone Marrow/Stem Cell Transplant Program
Georgia Regents University Cancer Center, Augusta, GA , USA
Division of Hematology and Oncology
University of Nebraska Medical center, USA
Table of Contents
About the Journal
Index Copernicus Value 2015: 62.09
Journal of Hematology & Thromboembolic Diseases is a peer-reviewed medical journal that includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal. The editorial office promises a thorough peer review of the submitted manuscripts to ensure quality.
This is one of the best open access journals that aims to publish the most complete and reliable source of information on discoveries and current developments as original articles, review articles, case reports, short communications, etc. in the field and provides online access without any restrictions or subscriptions to researchers worldwide.
Journal of Hematology and Thromboembolic Diseases is a peer-reviewed journal, serving the International Scientific Community. This Hematology journal offers an open-access platform to the authors to publish their research outcome.
OMICS International organizes 1000+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ scholarly open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members.
“Hematology and Thromboembolic Diseases” is an open-access journal dedicated to publishing high-quality research in this field. The Journal is a vast repository of Hematological research with a very broad scope. In addition to featuring traditional hematology topics such as Thalassemia, Sickle Cell Disease, Hemolytic Anemia, Rh incompatibility, Myelodysplastic Syndrome, Aplastic Anemia, Spherocytosis, Donor blood/Allo-immunization, embolism, and Von Willebrand's disease, the Journal also features a broad range of ancillary research including, but not restricted to Hematological Oncology, Immunotherapy, AIDS/HIV, Hepatitis C etc.
Every manuscript is subject to the vigorous peer-review process and is approved for publication on the recommendations of distinguished scientists in the field. The published content, therefore, ensures quality and originality. Apart from research articles, the Journal also publishes high-quality Commentaries, Reviews, Case Reports, and Perspectives of pivotal importance. The team at “Hematology and Thromboembolic Diseases” takes immense pride in providing the authors with an efficient and unbiased publishing process.
The journal provides rapid turn-around time for manuscript processing; the advance posting of accepted articles is another advantageous feature. “Hematology and Thromboembolic Diseases” presents an encouraging platform for authors to contribute their valuable findings towards the field.
Fast Editorial Review Process
is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in Journal of Hematology & Thromboembolic Diseases have been cited by esteemed scholars and scientists all around the world. Journal of Hematology & Thromboembolic Diseases has got h-index 16 , which means every article in Journal of Hematology & Thromboembolic Diseases has got 16 average citations.